Literature DB >> 15151269

Secondary IgA nephropathy presenting as nephrotic syndrome with glomerular crescentic changes and acute renal failure in a patient with autoimmune hepatitis.

Naveen Singri1, Briana Gleason, Steve L Flamm, Yashpal S Kanwar, Cybele Ghossein.   

Abstract

Patients with end-stage liver disease are prone to hemodynamic and immunologic renal injury, the latter at times manifesting as glomerulonephritis. Elevated serum immunoglobulin A (IgA) levels and mesangial IgG-IgA deposits are common in these patients, but are often clinically silent. We report a patient with autoimmune hepatitis and secondary IgA nephropathy (IgAN) who presented with nephrotic syndrome, acute renal failure (ARF), with 30% of the renal glomeruli having undergone crescentic change, and with IgA2 deposits in the glomerular mesangium. This article discusses secondary IgAN pathogenesis and its therapeutic management.

Entities:  

Mesh:

Year:  2004        PMID: 15151269

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  4 in total

1.  Association of liver cirrhosis related IgA nephropathy with portal hypertension.

Authors:  Georgios Kalambokis; Leonidas Christou; Dimitrios Stefanou; Evdokia Arkoumani; Epameinondas V Tsianos
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

Review 2.  Kidneys in chronic liver diseases.

Authors:  Marek Hartleb; Krzysztof Gutkowski
Journal:  World J Gastroenterol       Date:  2012-06-28       Impact factor: 5.742

3.  Clinical Profile and HLA Typing of Autoimmune Hepatitis From Pakistan.

Authors:  Nasir Hassan; Adeelur Rehman Siddiqui; Zaigham Abbas; Syed Mujahid Hassan; Ghous Bux Soomro; Muhammed Mubarak; Sabiha Anis; Rana Muzaffar; Mirza Naqi Zafar
Journal:  Hepat Mon       Date:  2013-12-16       Impact factor: 0.660

4.  Autoimmune hepatitis in a patient with immunoglobulin A nephropathy: A case report.

Authors:  You Hyun Jeon; Da Woon Kim; So Jeong Lee; Young Joo Park; Hyo Jin Kim; Miyeun Han; Il Young Kim; Dong Won Lee; Sang Heon Song; Soo Bong Lee; Eun Young Seong
Journal:  World J Clin Cases       Date:  2020-09-06       Impact factor: 1.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.